Alvogen, Inc recalls Levothyroxine Sodium Tablets
- Recalling company
- Alvogen, Inc
- Product
- Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Reason
- Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 31, 2025
- Reported
- Jan 21, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Lot / codes
- Lot # MHA21825, Exp Date: December 31, 2027
- Company location
- Morristown, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0259-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0259-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.